Pfizer (WBO:PFE) Other Current Payables : €2,175 Mil (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Pfizer Other Current Payables?

Pfizer's Other Current Payables for the quarter that ended in Dec. 2023 was €2,175 Mil.

Pfizer's quarterly Other Current Payables declined from Jun. 2023 (€2,137 Mil) to Sep. 2023 (€0 Mil) but then increased from Sep. 2023 (€0 Mil) to Dec. 2023 (€2,175 Mil).

Pfizer's annual Other Current Payables increased from Dec. 2021 (€1,990 Mil) to Dec. 2022 (€2,174 Mil) and increased from Dec. 2022 (€2,174 Mil) to Dec. 2023 (€2,175 Mil).

Pfizer Other Current Payables Historical Data

The historical data trend for Pfizer's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Other Current Payables Chart

Pfizer Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Payables

Get a 7-Day Free Trial

1,893.60

1,777.16

1,990.37

2,174.03

2,175.12

Pfizer Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Current Payables	Get a 7-Day Free Trial															2,174.03	-	2,136.75	-	2,175.12

Pfizer Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Pfizer Other Current Payables Related Terms

Thank you for viewing the detailed overview of Pfizer's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.

Pfizer (WBO:PFE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (WBO:PFE) » Definitions » Other Current Payables

Comparable Companies

Traded in Other Exchanges

PFE:USA PFE:Peru PFE:Mexico PFE_KZ:Kazakhstan 1PFE:Italy PFEd:UK 0Q1N:UK PFE:Germany PFE:Chile PFE:Canada PFIZ34:Brazil PFE:Argentina

Address

66 Hudson Boulevard East, New York, NY, USA, 10001-2192

Website

https://www.pfizer.com

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.